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Evidence has been presented in the fetal lamb (1, 2), the opossum (3), and
mouse (4) suggesting that the mammalian fetus attains immunologic compe-
tence to different antigens at different and discrete stages of its development.
Thus, immunologic maturation appears as a well-ordered stepwise process, with
some antigens able to elicit active immune responses very early in gestation and
other antigens appearing unable to stimulate detectable responses until laterin
gestation or even during the neonatal period. It has always been tempting to
identify the critical maturational eventresponsible for the sudden appearance of
competence to a given antigen with the development of the antigen-specific
receptorson immunocytes. However, Decker and co-workers (5, 6) have recently
reported that antigen-specific B cells may develop in the fetus long before it is
capable of forming antibody to that antigen. In the present report, we provide
evidence thatthe appearance offunctional, antigen-specific helper T cells in the
fetal lamb also precedes the ability of the fetus to mount a specific antibody
response.
Materials and Methods
The Experimental Protocol.
￿
Random-bred fetal lambs of known gestational age were immu-
nizedin utero, employingsurgical techniques previously described (7). ThetechniqueofRajewsky
et al. (8), as extendedby Katz et al. (9), was employed to assess thepresence ofhelper Tcells, using
the following scheme. Six fetal lambs were given a priming injection of 1 mg of dinitrophenyl-
keyhole limpet hemocyanin (DNP-KLH) intravenously in saline at 82 days gestation. 1 wk later,
three of these animals received a supplementary injection of 100 hg of ovalbumin (Oval) in
complete Freund's adjuvant distributed into intramuscular sites. At 105 days gestation, allof the
animalsreceived a booster injection of 1 mg ofDNP-Oval intravenously in saline, and all animals
were bled 7 days later at 112 days gestation.
Anti-DNP Antibody Assay.
￿
Thetechnique employed fortitration of anti-DNP antibodies was
thebacteriophage plaque inhibition assay ofMakela (10) as appliedby Segal et al. (11), usingDNP
coupled to T4 phage.
Results and Discussion
The data in Table I show thatafterpriming ofthe fetus with DNP-KLH, only
those animals which had received the ovalbumin supplement formed anti-DNP
antibody when boosted with DNP on the second carrier, ovalbumin. Previous
studies with this system had demonstrated that control animals immunized
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TABLE I
DNP-T4 Phage Neutralization Assay for Anti-DNP Antibodies
AfterPriming with DNP-KLH and Boosting With DNP-Oval
With and Without an Intermediate Oval Supplement
803
with DNP-KLH or DNP-ovalbumin alone by the intravenous route formed no
anti-DNP antibodies. Since formation ofanti-DNP on protein carriers is gener-
ally considered to be a T-cell-dependent process, it is evident that the ovalbu-
min-in-adjuvant supplement served in this instance to stimulate ovalbumin-
specific T cells able to satisfy the helper function required by this system, as
early as 112 days gestation in the fetal lamb.
Whereas hemocyanin is capable by itself of eliciting an active antibody
response before 80-odd days gestation, we have found repeatedly that the fetal
lamb is incapable of mounting an antiovalbumin response before 120 days
gestation. These data would suggest, therefore, that ovalbumin-specific T cells
may mature and function in the fetal lamb before full immunologic competence
to this antigen is manifested. The present data, taken together with the report
by Decker and Sercarz (6) that the appearance of ovalbumin-specific B cells in
the fetal lamb also antecedes the attainment ofcompetence tothis antigen, raise
again the question of the nature of the critical event that occurs at about 120
days to enable the fetal lamb to form antiovalbumin antibody. The precise
timing of the maturational sequence of immunologic competence to different
antigens at precise stages ofdevelopment suggests that this is not a question of
general control, but ofspecific recognition mechanisms, since other B and T-cell
systems are present and working much earlier in gestation (e.g., bacteriophage
OX 174at less than 40 days gestation, ferritin at 56days gestation, etc.-see ref.
2). These findings in the fetal lamb are consistent with the demonstrations (5,
12, 13) that both T and B cells may arise very early during ontogeny in other
mammalian species.
It is, ofcourse, possible that the critical maturational event for each antigen
does not concern specific immunocytes, but rather reflectsthe sequential matur-
ation of fetal ability to process appropriately the several antigens. Alterna-
tively, since we have demonstrated the early presence of functional antigen-
specific helper T cells, the critical event may operate at the level of the B cell.
Thus, Mosier and Johnson (14) speculate that specific suppressor T cells may be
present in excess during early development to inhibit normal B-cell function .
However, we currently feel it more likely that an additional differentiative step
may be required by the B cell, even after specific receptors develop. This event
(the appearance ofanIr-gene product?)would then permit the B cell to translate
antigen-receptor interactions into the signals required for the full-scale turn-on
of genes necessary for the production ofexportable antibody.
Fetal lamb Oval supplement Dilution of serum for
50% neutralization
E261 Yes 1:10,000
E262 Yes >1:10,000
E39-1 Yes 1:3,500
E3-2 No <1:10
E25-1 No <1:10
E39-2 No <1:10804
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Summary
Although the fetal lamb is unable to form circulating antiovalbumin antibod-
ies until about 120 days of gestation, ovalbumin-specific helper T cells can be
stimulated to function at an earlier age . This would suggest that the critical
event responsible for the precise sequential maturation of immunologic compe-
tence to different antigens at different developmental stages is not the first
appearance of specific receptors on immunocytes. Alternative explanations of
this phenomenon are discussed.
Received for publication 3 June 1975 .
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